Note that there is a pattern in which the VGluT2 immunofluorescence intensity in AD is slightly stronger than that in AV, which is consistent with previous research (Oda et al., 2014; Supplementary Figure 2). This evidence concerns the gene SLC17A6 and Alzheimer disease.